CONCORDE -a phase Ib platform study of novel agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC)
Horne, Ashley Brown, S. Butterworth, K. Chalmers, A. Collinson, F. Faivre-FInn, Corinne Forster, M. Franks, K. Gilbert, A.
Horne, Ashley
Brown, S.
Butterworth, K.
Chalmers, A.
Collinson, F.
Faivre-FInn, Corinne
Forster, M.
Franks, K.
Gilbert, A.
Citations
Altmetric:
Abstract
Authors
Horne, Ashley
Brown, S.
Butterworth, K.
Chalmers, A.
Collinson, F.
Dive, Caroline
Faivre-FInn, Corinne
Forster, M.
Franks, K.
Gilbert, A.
Hallam, M.
Hanna, G.
Harrow, S.
Hartley, J.
Hiley, C.
Jones, R.
Katona, E.
Kendall, J.
Krebs, Matthew G
Mallison, G.
Oughton, J. B.
Phillip, R.
Rothwell, Dominic G
Sebag Montefiore, D.
Shaw, P.
Walls, G.
Walker, F.
Young, R.
Greystoke, A.
Brown, S.
Butterworth, K.
Chalmers, A.
Collinson, F.
Dive, Caroline
Faivre-FInn, Corinne
Forster, M.
Franks, K.
Gilbert, A.
Hallam, M.
Hanna, G.
Harrow, S.
Hartley, J.
Hiley, C.
Jones, R.
Katona, E.
Kendall, J.
Krebs, Matthew G
Mallison, G.
Oughton, J. B.
Phillip, R.
Rothwell, Dominic G
Sebag Montefiore, D.
Shaw, P.
Walls, G.
Walker, F.
Young, R.
Greystoke, A.
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Horne A, Brown S, Butterworth K, Chalmers A, Collinson F, Dive C, et al. CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 2022 Sep;17(9):S267-S8. PubMed PMID: WOS:000858678100440.